Article
Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies.
Journal of viral hepatitis - 1 Dec 2020
Perpiñán Elena, Pérez-Del-Pulgar Sofía, Londoño María-Carlota, Mariño Zoe, Lens Sabela, Leonel Thais, Bartres Concepción, García-López Mireia, Rodriguez-Tajes Sergio, Forns Xavier, Koutsoudakis George
Abstract excerpt
Chronic hepatitis C virus (HCV) infection impairs HCV CD8+ T-cell responses, while it could influence immune responses towards unrelated viruses/vaccines (e.g. cytomegalovirus, CMV, and influenza, Flu). The aim of our study was to delineate whether restoration of these virus-specific CD8+ T cells occurs after direct-acting antiviral (DAA) therapies and particularly in patients with cirrhosis. We performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
